Core Viewpoint - The approval of the collagen implant product by the National Medical Products Administration marks a significant milestone for the company, being the first collagen product in China for dermal injection to improve cheek smoothness [1][2]. Group 1: Product Details - The product is a natural cross-linked complete type I collagen fiber, featuring a stable triple helix structure that self-assembles into an ordered fibrous supramolecular structure [1]. - The implantation of this product can supplement the collagen framework in the dermis of the cheeks, improving extracellular matrix metabolism and enhancing skin texture and elasticity [1]. - The innovative technology includes a proprietary ultra-pure extraction process and precise peptide cleavage, ensuring the amino acid sequence and composition are consistent with human type I collagen at the molecular level [1]. Group 2: Technological and Developmental Implications - The core technology of the product stems from the company's years of expertise in the collagen field, laying the groundwork for future products such as type II and type III collagen [2]. - The successful launch of this product represents a milestone achievement for the company's original research and innovation platform in animal-derived implant materials, showcasing the advantages of the company's platform-based operations [2].